Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.77
+0.28 (2.24%)
At close: Jul 1, 2025, 4:00 PM
12.52
-0.25 (-1.96%)
After-hours: Jul 1, 2025, 6:43 PM EDT

Korro Bio Stock Forecast

KRRO's stock price has decreased by -62.3% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 7 analysts that cover Korro Bio stock have a consensus rating of "Strong Buy" and an average price target of $85.67, which forecasts a 570.87% increase in the stock price over the next year. The lowest target is $25 and the highest is $130.

Price Target: $85.67 (+570.87%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $25 $85.67 $95 $130
Change +95.77% +570.87% +643.93% +918.01%
* Price targets were last updated on May 13, 2025.

Analyst Ratings

The average analyst rating for Korro Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 333333
Buy 444454
Hold 000000
Sell 000000
Strong Sell 000000
Total 777787

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$25
Strong Buy Maintains $25 +95.77% May 13, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$155$90
Buy Maintains $155$90 +604.78% May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$115$100
Strong Buy Maintains $115$100 +683.09% May 8, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$74
Buy Initiates $74 +479.48% Apr 29, 2025
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$25
Strong Buy Initiates $25 +95.77% Apr 16, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.75M
from 2.27M
Increased by 65.08%
Revenue Next Year
1.30M
from 3.75M
Decreased by -65.30%
EPS This Year
-9.74
from -9.37
EPS Next Year
-9.25
from -9.74
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
---2.27M3.75M1.30M510.00K3.19M
Revenue Growth
----65.08%-65.30%-60.80%525.29%
EPS
-4.94-227.42-53.08-9.37-9.74-9.25-9.68-12.08
EPS Growth
--------
Forward PE
--------
No. Analysts
----121297
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 8.1M 5.5M 3.2M
Avg 3.7M 1.3M 510,000
Low 2.5M n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
257.3%
45.6%
142.1%
Avg
65.1%
-65.3%
-60.8%
Low
10.0%
- -

EPS Forecast

EPS 20252026202720282029
High -8.91 -6.42 -2.85
Avg -9.74 -9.25 -9.68
Low -11.47 -14.19 -13.14

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.